EHS
EHS

FDA Nixes Approval of Buprenorphine Spray for Pain

Today the FDA turned down approval of Buvaya, a buprenorphine sublingual spray for moderate to severe pain because of reported safety concerns.
News Alerts

Source link

EHS
Back to top button